JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Metser, U.
Right arrow Articles by Even-Sapir, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Metser, U.
Right arrow Articles by Even-Sapir, E.

18F-FDG PET/CT in the Evaluation of Adrenal Masses

Ur Metser, MD1,2, Elka Miller, MD2, Hedva Lerman, MD1, Gennady Lievshitz, MD1, Shmuel Avital, MD3 and Einat Even-Sapir, MD, PhD1

1 Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; 2 Department of Radiology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; and 3 Department of Surgery A, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel



View larger version (18K):

[in a new window]
 
FIGURE 1.  Diagnostic algorithm for characterizing adrenal masses. NCCT = unenhanced CT; CECT = contrast-enhanced CT.

 


View larger version (8K):

[in a new window]
 
FIGURE 2.  Scatter plot of SUVs (y-axis) of all adenomas (B) and all malignant lesions (M).

 


View larger version (162K):

[in a new window]
 
FIGURE 3.  False-positive 18F-FDG PET findings in 59-y-old woman with metastatic colorectal cancer. Coronal 18F-FDG PET/CT images (CT image on left, attenuation-corrected PET image in middle, and fusion image on right) show increased uptake of 18F-FDG (SUV, 4.4) in 2-cm lipid-poor left adrenal adenoma (arrows).

 


View larger version (8K):

[in a new window]
 
FIGURE 4.  ROC analysis for different cutoff values of HU and SUV in differentiating benign from malignant adrenal masses: 99% ({blacksquare}) and 92% ({blacktriangleup}) probabilities for malignancy.

 


View larger version (48K):

[in a new window]
 
FIGURE 5.  53-y-old man with melanoma. Axial PET/CT images (CT image on left, attenuation-corrected PET image in middle, and fusion image on right) show no abnormal uptake of 18F-FDG (SUV, 1.2) in 1.4-cm soft-tissue–attenuating left adrenal mass (38 HU), stable on imaging for 8 mo, suggestive of lipid-poor adenoma (arrows).

 


View larger version (42K):

[in a new window]
 
FIGURE 6.  75-y-old woman with metastatic lung cancer. Axial PET/CT image (CT image on left, attenuation-corrected PET image in middle, and fusion image on right) shows abnormal uptake of 18F-FDG (SUV, 7.8–16.9) in soft-tissue–attenuating masses (28–36 HU) in both adrenal glands, consistent with metastatic deposits (arrows).

 


View larger version (43K):

[in a new window]
 
FIGURE 7.  66-y-old man with disseminated metastatic disease due to lung cancer. Axial PET/CT image shows abnormal uptake of 18F-FDG (SUV, 16.8) in 0.6-cm soft-tissue–attenuating (36 HU) mass in medial portion of left adrenal gland, consistent with metastatic deposit (arrows). Large metastatic deposit is seen in left kidney.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2006 by the Society of Nuclear Medicine.